Trial Profile
A double-blind randomized, placebo-controlled, single-center study to assess the impact of statins on the autonomic nervous system and cardiac structure/function in non-ischemic heart failure
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Atorvastatin (Primary)
- Indications Heart failure
- Focus Pharmacodynamics
- 30 Mar 2012 Additional lead trial centre and investigator (Tamara B Horwich) identified as reported by ClinicalTrials.gov.
- 30 Mar 2012 Actual end date (Feb 2009) added as reported by ClinicalTrials.gov.
- 30 Mar 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.